Sun Pharma to acquire Organon for USD 11.75 billion in one of India’s largest overseas deals - Prop News Time
Sun Pharmaceutical Industries→Organon
Apr 29, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
CareDx has acquired Naveris, a diagnostics imaging business in New York, for $260 million. Naveris supports cancer diagnostics with viral-mediated testing capabilities, strengthening CareDx’s diagnostics imaging platform for oncology patients. CareDx acquisitions are focused on expanding into MRD and related cancer monitoring workflows, leveraging Naveris technology to broaden clinical offerings across NY. The CareDx acquisitions are structured as a platform acquisition and strategic acquisition within healthcare M&A, with deal size over $100M and an announced status.
Filed under
Source
Read full article on finance.yahoo.comvia GN - entered into definitive agreement · April 29, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Sun Pharmaceutical Industries→Organon
Apr 29, 2026
UConn Health→Day Kimball Hospital and Bristol Health
Apr 28, 2026
Asante→Surgery Center of Southern Oregon
Apr 28, 2026
CareDx→Naveris
Apr 28, 2026
Eli Lilly→Ajax Therapeutics
Apr 28, 2026